Infantile Hemangioma: A Retrospective Study
Downloads
Background: Infantile Hemangioma (IH) is a benign vascular neoplasm and most commonly found in newborns. IH appears in the first few weeks of life and mostly resolve immediately. Early recognition of symptoms, diagnosis, and therapy has an important role in determining the prognosis of this condition. Purpose: The purpose of this study is to evaluate the clinical features of new IH patients in the Pediatric Dermatology Division of the Dermatology & Venereology Department outpatient clinic of Dr. Soetomo General Hospital Surabaya in 2008-2017. Methods: This is a retrospective descriptive study from the medical records of new IH patients over a period of 10 years (2008-2017). Results: A total of 84 new IH patients were observed in this study. The data showed that: the most age group was 0-1 year old (71.43%), female (63.1%), and no family history of a similar condition (94.05%). The most common complaint reported was the presence of bumps (59.52%). Most complaints occurred before the patients turned one year old (89.29%) and involved the facial region (58.33%). From the clinical features, the most frequent skin lesions were macules (35.36%). In addition, there was a combination of macular and nodular lesions in 28.13% of patients. The most widely used therapy is laser modality found in 55.45% of patients. Conclusion: Clinical features of IH patients, in accordance with the theory and treatment choices, dependent on the patients' conditions and clinical manifestations of the disease.
Mathes EF, Frieden IJ. Vascular tumors. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. p. 1456-65.
George A, Mani V, Noufal A. Update on the classification of hemangioma. J Oral Maxillofac Pathol 2014; 18(1): 117–20.
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390(10089): 85–94.
Mendiratta V, Jabeen M. Infantile hemangioma: an update. Indian J Dermatol Venereol 2010; 76(5): 469–76.
Greene AK. Management of hemangiomas and other vascular tumors. Clin Plast Surg 2011; 38(1): 45–63.
Reimer A, Fliesser M, Hoeger PH. Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). J Am Acad Dermatol 2016; 75(3): 556–63.
Callahan AB, Yoon MK. Infantile hemangiomas: a review. Saudi J Ophthalmol 2014; 26(3): 283–91.
Restrepo R, Palani R, Cervantes LF, Duarte A, Amjad I, Altman NR. Hemangiomas revisited: the useful , the unusual and the new. Pediatr Radiol 2011; 41(7):895–915.
Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: a systematic review. Lasers Surg Med 2016; 48(3): 221–33.
Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012; 2012: 645-78.
Chen TS, Eichenfield LF, Friedlander SF. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 2013; 131(1): 99–108.
Laken PA, Forsythe PL. Infantile hemangiomas: pathogenesis and review of propranolol use. Adv Neonatal Care 2016; 16(2): 135–42.
Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am 2014; 61(2): 383–402.
Moyakine AV, Herwegen B, van der Vleuten CJM. Use of the hemangioma severity scale to facilitate treatment decisions for infantile hemangiomas. J Am Acad Dermatol 2017; 77(5): 868–73.
Suh K-Y, Frieden IJ. Infantile hemangiomas with minimal or arrested growth. Arch Dermatol 2010; 146(9): 971–6.
Brauer JA, Geronemus RG. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol 2013; 16(1): 51–4.
Ames JA, Sykes JM. Current trends in medical management of infantile hemangioma. Curr Opin Otolaryngol Head Neck Surg 2015; 23(4): 286–91.
Darrow DH, Greene AK, Mancini AJ, Nopper AJ. Diagnosis and management of infantile hemangioma. Pediatrics 2015; 136(4): e1060–104.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
